GE's Discovery NM/CT 670
GE's new SPECT/CT hybrid gets FDA OK
October 12, 2010
by Brendon Nafziger, DOTmed News Associate Editor
GE Healthcare said Monday its next-generation hybrid SPECT/CT was cleared by the U.S. Food and Drug Administration and is headed to U.S. shores.
At the European Society of Nuclear Medicine conference in Vienna, GE said it got 510(k) clearance for its Discovery NM/CT 670. The machine combines its BrightSpeed Elite 16-slice CT with a newly built SPECT gantry, the company said.
GE released the first SPECT/CT hybrid in 1999.
In its marketing material, the Waukesha, Wisc.-based company said the newer, speedier technology lets it cut traditional bone imaging scan times by half.
GE spokeswoman Rebecca Hayne told DOTmed News four units of the device are scheduled for installation in the United States. To date, more than 25 have been ordered around the world, she said.
Although GE announced the clearance this week, the unit was actually cleared by the FDA in December, Hayne said. It launched in Europe last year.
At the European Society of Nuclear Medicine conference in Vienna, GE said it got 510(k) clearance for its Discovery NM/CT 670. The machine combines its BrightSpeed Elite 16-slice CT with a newly built SPECT gantry, the company said.
GE released the first SPECT/CT hybrid in 1999.
In its marketing material, the Waukesha, Wisc.-based company said the newer, speedier technology lets it cut traditional bone imaging scan times by half.
GE spokeswoman Rebecca Hayne told DOTmed News four units of the device are scheduled for installation in the United States. To date, more than 25 have been ordered around the world, she said.
Although GE announced the clearance this week, the unit was actually cleared by the FDA in December, Hayne said. It launched in Europe last year.